Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Short term Debt: 2009-2019

Historic Short term Debt for Avadel Pharmaceuticals (AVDL) over the last 11 years, with Dec 2019 value amounting to $5.6 million.

  • Avadel Pharmaceuticals' Short term Debt was N/A to $26.3 million in Q3 2022 from the same period last year, while for Sep 2022 it was $26.3 million, marking a year-over-year change of. This contributed to the annual value of $5.6 million for FY2019, which is 41.16% down from last year.
  • Avadel Pharmaceuticals' Short term Debt amounted to $5.6 million in FY2019, which was down 41.16% from $9.4 million recorded in FY2018.
  • Avadel Pharmaceuticals' 5-year Short term Debt high stood at $34.2 million for FY2016, and its period low was $5.6 million during FY2019.
  • Its 3-year average for Short term Debt is $13.3 million, with a median of $9.4 million in 2018.
  • Its Short term Debt has fluctuated over the past 5 years, first spiked by 35.60% in 2016, then plummeted by 62.25% in 2018.
  • Yearly analysis of 5 years shows Avadel Pharmaceuticals' Short term Debt stood at $25.2 million in 2015, then surged by 35.60% to $34.2 million in 2016, then declined by 26.83% to $25.0 million in 2017, then slumped by 62.25% to $9.4 million in 2018, then slumped by 41.16% to $5.6 million in 2019.